Public comments can be made on the proposed changes until September 26th, at which point a hearing will be held.
Public comments can be made on the proposed changes until September 26th, at which point a hearing will be held.
Discussions centered around the proposed medical fee schedule, particularly the Medicare negotiated pricing for pharmaceuticals.
Two recent committee meetings addressed access to care, exclusive remedy, and more.
Topics covered included recent MTUS updates, the pharmacy fee schedule update, UR and IMR updates, and more.
Stakeholders can submit feedback on the research agenda by September 15th.
Public comments will be accepted on the current fee schedule until September 7th.
The DoWC discussed requirements from the recently enacted House Bill 1300, which mandates vast workers’ comp reforms.
Recommended changes will be reviewed by the WCB and MSRC on August 22nd, with final adoption expected in October, and taking effect in 2026.
Open to public comment until September 12th, the guideline is intended to establish best practices for diagnosis and treatment.
The Office of Administrative Law informed the DWC that seven areas of the proposed update required additional clarification or public notice.
The proposed changes would impact reimbursement rates, telehealth services, and much more.
The meeting covered 2024 healthcare costs and utilization, along with incoming regulatory changes.
The meeting covered fee schedule policies impacting physician-dispensed medication, electronic delivery for EOBs, and more.
The next meeting in October will deliver an expanded formulary list, with a review of the top five to ten exempt drugs based on utilization.
The July 16th meeting will review upcoming MTUS changes, which go into effect August 6th.
